SCHEMBL20051692

SCHEMBL20051692

CCc1ccc(C2=Cc3ccc4c(c3OC2)C=CC(C)(C)O4)c(OS(=O)(=O)c2ccc(C)cc2)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 1/20 0.39
▸ ODC1 P11926 1/20 0.38
▸ HSP90AA1 P07900 3/20 0.37
▸ TP53 P04637 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CNR2 P34972 5/20 0.35
▸ CNR1 P21554 4/20 0.35
▸ HIF1A Q16665 9/20 0.34
▸ EPAS1 Q99814 8/20 0.34
▸ TLR3 O15455 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20051767 0.94 TYR (0.38) TYRODC1HSP90AA1TP53CYP3A4
SCHEMBL20051750 0.93 CNR2 (0.40) TYRODC1HSP90AA1TP53CYP3A4
SCHEMBL23398012 0.92 CNR2 (0.42) TYRODC1HSP90AA1TP53CYP3A4
SCHEMBL21254262 0.89 TYR (0.38) TYRODC1HSP90AA1TP53CYP3A4
SCHEMBL21254126 0.88 ACHE (0.41) TYRODC1HSP90AA1TP53CYP3A4
SCHEMBL21254269 0.88 TYR (0.37) TYRODC1HSP90AA1TP53CYP3A4
SCHEMBL21254071 0.88 TYR (0.37) TYRODC1HSP90AA1TP53CYP3A4
SCHEMBL20051755 0.85 TYR (0.36) TYRODC1HSP90AA1TP53CYP3A4
SCHEMBL23017796 0.84 TYR (0.39) TYRODC1SMN1; SMN2HIF1AEPAS1
SCHEMBL23398016 0.83 CNR1 (0.35) TYRODC1HSP90AA1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524609-B1 PROCESS FOR THE PREPARATION OF 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVES, OPTICAL ISOMERS THEREOF, AND INTERMEDIATES OF THE PROCESS GLACEUM INC (KR) 2021-05-26 — — EP disclosed
US-10947250-B2 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and method for synthesizing optical isomer thereof GLACEUM, INC. 2021-03-16 — — US disclosed
US-20210040106-A1 METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE Glaceum Inc. (KR) 2021-02-11 — — US disclosed
US-20200199142-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF GLACEUM INC (KR) 2020-06-25 — — US disclosed
US-10669282-B2 Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof GLACEUM, INC. (KR) 2020-06-02 — — US disclosed
US-20200048272-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF GLACEUM, INC. (KR) 2020-02-13 — — US disclosed
WO-2019194582-A1 METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE 주식회사 글라세움 2019-10-10 — — WO disclosed
EP-3524609-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF Glaceum, Inc. (KR) 2019-08-14 — — EP disclosed
WO-2018066872-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF 주식회사 글라세움 2018-04-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10669282-B2 Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof CYP2J2, CYP2A13, HPD TYR 23/4885ODC1 1009/4885HSP90AA1 4806/4885
US-20200199142-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF CYP2J2, HPD, CYP2A13 TYR 53/4885ODC1 1888/4885HSP90AA1 4569/4885
US-20200048272-A1 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF CYP2J2, HPD, CYP2A13 TYR 53/4885ODC1 1888/4885HSP90AA1 4569/4885
US-10947250-B2 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and method for synthesizing optical isomer thereof CYP2J2, HPD, CYP2A13 TYR 53/4885ODC1 1888/4885HSP90AA1 4569/4885
US-20210040106-A1 METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE HPD, CYP2J2, PAH TYR 12/4885ODC1 2294/4885HSP90AA1 3318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback